Citigroup Inc Vaxxinity, Inc. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.62 - $0.86 $640 - $888	1,033 Added 17.02%	7,101 $5,000
Q4 2023 Feb 09, 2024	BUY	$0.7 - $1.31 $4,232 - $7,920	6,046 Added 27481.82%	6,068 $5,000
Q3 2023 Nov 09, 2023	SELL	$1.25 - $3.0 $15,838 - $38,013	-12,671 Reduced 99.83%	22 $0
Q2 2023 Aug 10, 2023	BUY	$1.73 - $2.79 $21,958 - $35,413	12,693 New	12,693 $31,000
Q2 2022 Aug 10, 2022	BUY	$1.55 - $6.95 $2,242 - $10,056	1,447 New	1,447 $2,000

287K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Market Cap $1.12M
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.